Triple
T4200711
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Zaire ebolavirus |
E86056
|
entity |
| Predicate | approvedVaccine |
P35116
|
FINISHED |
| Object | rVSV-ZEBOV |
E85063
|
NE FINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: rVSV-ZEBOV | Statement: [Zaire ebolavirus, approvedVaccine, rVSV-ZEBOV]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: rVSV-ZEBOV Context triple: [Zaire ebolavirus, approvedVaccine, rVSV-ZEBOV]
-
A.
rVSV-ZEBOV
chosen
rVSV-ZEBOV is an experimental recombinant vesicular stomatitis virus-based vaccine developed to protect humans against infection by the Zaire strain of the Ebola virus.
-
B.
Ebolavirus
Ebolavirus is a genus of filamentous, enveloped RNA viruses in the Filoviridae family that cause severe and often fatal hemorrhagic fever in humans and other primates.
-
C.
Zaire ebolavirus
Zaire ebolavirus is a highly virulent species of Ebola virus responsible for severe hemorrhagic fever outbreaks in humans, including the major 2014–2016 epidemic in West Africa.
-
D.
Reston ebolavirus
Reston ebolavirus is a species of ebolavirus that primarily infects nonhuman primates and pigs and is notable for being the only known ebolavirus that has caused asymptomatic infections in humans.
-
E.
Leqembi
Leqembi is an Alzheimer’s disease drug (lecanemab) that targets amyloid-beta plaques to slow cognitive decline in early-stage patients.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: approvedVaccine Context triple: [Zaire ebolavirus, approvedVaccine, rVSV-ZEBOV]
-
A.
vaccineUsed
Indicates that a particular vaccine has been administered or applied in a given medical or experimental context.
-
B.
approvedAt
Indicates the date and time at which an entity received formal approval.
-
C.
hasVaccine
chosen
Indicates that one entity possesses, provides, or is associated with a specific vaccine in relation to another entity.
-
D.
approvedBy
Indicates that an action, request, or item has received formal authorization or consent from a specified entity.
-
E.
approvedInCountry
Indicates that an entity has received official authorization or approval within the jurisdiction of a specified country.
- F. None of above.
Provenance (4 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69aed93b89f48190a31f6d57c760e42f |
completed | March 9, 2026, 2:29 p.m. |
| NER | Named-entity recognition | batch_69af0363bbb8819093f396afe91972e2 |
completed | March 9, 2026, 5:29 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69b58a14eda88190aaca14644c3e041a |
completed | March 14, 2026, 4:17 p.m. |
| PD | Predicate disambiguation | batch_69af01959c4881909eb1adcb3bdadbe6 |
completed | March 9, 2026, 5:21 p.m. |
Created at: March 9, 2026, 3:49 p.m.